Please login to the form below

Not currently logged in
Email:
Password:

Rare Diseases and Orphan Drugs


Rare Diseases and Orphan Drugs

This category relates to the marketing of an orphan drug (for rare diseases or disorders), at any phase of the product life cycle. Entrants will need to demonstrate a thorough understanding of the specific environment and show appropriate marketing approach to drive the business forward.

Work conducted during the 18-month period between July 2010 and December 2011 will be eligible.


Judging criteria:

  • Recognition of the specific health environment
  • Evidence that the drug eas built upon customer insight
  • Explanation of positioning and evidence of effective brand building
  • Market access strategy & execution
  • Effective integration of tailored marketing tools and activities
  • Evidence of changed behaviours and enhanced health outcomes



Sponsors

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

digital healthcare chronic disease
Digital healthcare may revolutionise management of chronic diseases, but who is going to pay for it?
Providers are looking at digital solutions to transform this area of healthcare...
Live webinar:
The power of a good story: Turn your insights into effective storytelling with data visualisation...
clinical research org
The important role of CROs in shaping the future of clinical research across Europe
Looking at the impact of COVID-19 on clinical research activities...

Infographics